Exome Asset Management LLC Portfolio Holdings
Exome Asset Management LLC
- $112 Billion
- Q1 2025
Exome Asset Management LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $112 Billion distributed in 59 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $5.72B, Guardant Health, Inc. with a value of $5.42B, Geron Corp with a value of $5.11B, Astrazeneca PLC with a value of $4.73B, and Cytokinetics Inc with a value of $4.16B.
Examining the 13F form we can see an decrease of $20.6B in the current position value, from $133B to 112B.
Exome Asset Management LLC is based out at New York, NY
Below you can find more details about Exome Asset Management LLC portfolio as well as his latest detailed transactions.